4.8 Meeting Abstract

Interaction between DRD1 and childhood exposure to environmental tobacco smoke modulates lung cancer risk in smokers and never smokers.

Journal

CANCER RESEARCH
Volume 73, Issue 8, Pages -

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1538-7445.AM2013-4581

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Michael A. Gillette, Shankha Satpathy, Song Cao, Saravana M. Dhanasekaran, Suhas V. Vasaikar, Karsten Krug, Francesca Petralia, Yize Li, Wen-Wei Liang, Boris Reva, Azra Krek, Jiayi Ji, Xiaoyu Song, Wenke Liu, Runyu Hong, Lijun Yao, Lili Blumenberg, Sara R. Savage, Michael C. Wendl, Bo Wen, Kai Li, Lauren C. Tang, Melanie A. MacMullan, Shayan C. Avanessian, M. Harry Kane, Chelsea J. Newton, MacIntosh Cornwell, Ramani B. Kothadia, Weiping Ma, Seungyeul Yoo, Rahul Mannan, Pankaj Vats, Chandan Kumar-Sinha, Emily A. Kawaler, Tatiana Omelchenko, Antonio Colaprico, Yifat Geffen, Yosef E. Maruvka, Felipe da Veiga Leprevost, Maciej Wiznerowicz, Zeynep H. Gumus, Rajwanth R. Veluswamy, Galen Hostetter, David Heiman, Matthew A. Wyczalkowski, Tara Hiltke, Mehdi Mesri, Christopher R. Kinsinger, Emily S. Boja, Gilbert S. Omenn, Arul M. Chinnaiyan, Henry Rodriguez, Qing Kay Li, Scott D. Jewell, Mathangi Thiagarajan, Gad Getz, Bing Zhang, David Fenyo, Kelly Ruggles, Marcin P. Cieslik, Ana Robles, Karl R. Clauser, Ramaswamy Govindan, Pei Wang, Alexey Nesvizhskii, Li Ding, D. R. Mani, Steven A. Carr

Article Biochemistry & Molecular Biology

Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Yi-Ju Chen, Theodoros Roumeliotis, Ya-Hsuan Chang, Ching-Tai Chen, Chia-Li Han, Miao-Hsia Lin, Huei-Wen Chen, Gee-Chen Chang, Yih-Leong Chang, Chen-Tu Wu, Mong-Wei Lin, Min-Shu Hsieh, Yu-Tai Wang, Yet-Ran Chen, Inge Jonassen, Fatemeh Zamanzad Ghavidel, Ze-Shiang Lin, Kuen-Tyng Lin, Ching-Wen Chen, Pei-Yuan Sheu, Chen-Ting Hung, Ke-Chieh Huang, Hao-Chin Yang, Pei-Yi Lin, Ta-Chi Yen, Yi-Wei Lin, Jen-Hung Wang, Lovely Raghav, Chien-Yu Lin, Yan-Si Chen, Pei-Shan Wu, Chi-Ting Lai, Shao-Hsing Weng, Kang-Yi Su, Wei-Hung Chang, Pang-Yan Tsai, Ana Robles, Henry Rodriguez, Yi-Jing Hsiao, Wen-Hsin Chang, Ting-Yi Sung, Jin-Shing Chen, Sung-Liang Yu, Jyoti S. Choudhary, Hsuan-Yu Chen, Pan-Chyr Yang, Yu-Ju Chen

Editorial Material Oncology

Cytokine Storms in Cancer and COVID-19

Casmir Turnquist, Brid M. Ryan, Izumi Horikawa, Brent T. Harris, Curtis C. Harris

CANCER CELL (2020)

Article Oncology

Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

Chen Huang, Lijun Chen, Sara R. Savage, Rodrigo Vargas Eguez, Yongchao Dou, Yize Li, Felipe da Veiga Leprevost, Eric J. Jaehnig, Jonathan T. Lei, Bo Wen, Michael Schnaubelt, Karsten Krug, Xiaoyu Song, Marcin Cieslik, Hui-Yin Chang, Matthew A. Wyczalkowski, Kai Li, Antonio Colaprico, Qing Kay Li, David J. Clark, Yingwei Hu, Liwei Cao, Jianbo Pan, Yuefan Wang, Kyung-Cho Cho, Zhiao Shi, Yuxing Liao, Wen Jiang, Meenakshi Anurag, Jiayi Ji, Seungyeul Yoo, Daniel Cui Zhou, Wen-Wei Liang, Michael Wendl, Pankaj Vats, Steven A. Carr, D. R. Mani, Zhen Zhang, Jiang Qian, Xi S. Chen, Alexander R. Pico, Pei Wang, Arul M. Chinnaiyan, Karen A. Ketchum, Christopher R. Kinsinger, Ana Robles, Eunkyung An, Tara Hiltke, Mehdi Mesri, Mathangi Thiagarajan, Alissa M. Weaver, Andrew G. Sikora, Jan Lubinski, Malgorzata Wierzbicka, Maciej Wiznerowicz, Shankha Satpathy, Michael A. Gillette, George Miles, Matthew J. Ellis, Gilbert S. Omenn, Henry Rodriguez, Emily S. Boja, Saravana M. Dhanasekaran, Li Ding, Alexey Nesvizhskii, Adel K. El-Naggar, Daniel W. Chan, Hui Zhang, Bing Zhang

Summary: This study presents a proteogenomic analysis of HPV-negative HNSCCs, identifying potential therapeutic targets and uncovering tumor characteristics such as immune status and resistance mechanisms. The findings suggest new strategies for stratifying HNSCC and improving treatment outcomes.

CANCER CELL (2021)

Article Biochemistry & Molecular Biology

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Francesca Petralia, Nicole Tignor, Boris Reva, Mateusz Koptyra, Shrabanti Chowdhury, Dmitry Rykunov, Azra Krek, Weiping Ma, Yuankun Zhu, Jiayi Ji, Anna Calinawan, Jeffrey R. Whiteaker, Antonio Colaprico, Vasileios Stathias, Tatiana Omelchenko, Xiaoyu Song, Pichai Raman, Yiran Guo, Miguel A. Brown, Richard G. Ivey, John Szpyt, Sanjukta Guha Thakurta, Marina A. Gritsenko, Karl K. Weitz, Gonzalo Lopez, Selim Kalayci, Zeynep H. Gumus, Seungyeul Yoo, Felipe Veiga Leprevost, Hui-Yin Chang, Karsten Krug, Lizabeth Katsnelson, Ying Wang, Jacob J. Kennedy, Uliana J. Voytovich, Lei Zhao, Krutika S. Gaonkar, Brian M. Ennis, Bo Zhang, Valerie Baubet, Lamiya Tauhid, Jena Lilly, Jennifer L. Mason, Bailey Farrow, Nathan Young, Sarah Leary, Jamie Moon, Vladislav A. Petyuk, Javad Nazarian, Nithin D. Adappa, James N. Palmer, Robert M. Lober, Samuel Rivero-Hinojosa, Liang-Bo Wang, Joshua M. Wang, Matilda Broberg, Rosalie K. Chu, Ronald J. Moore, Matthew E. Monroe, Rui Zhao, Richard D. Smith, Jun Zhu, Ana Robles, Mehdi Mesri, Emily Boja, Tara Hiltke, Henry Rodriguez, Bing Zhang, Eric E. Schadt, D. R. Mani, Li Ding, Antonio Iavarone, Maciej Wiznerowicz, Stephan Schurer, Xi S. Chen, Allison P. Heath, Jo Lynne Rokita, Alexey Nesvizhskii, David Fenyo, Karin D. Rodland, Tao Liu, Steven P. Gygi, Amanda G. Paulovich, Adam C. Resnick, Phillip B. Storm, Brian R. Rood, Pei Wang

Article Oncology

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, Alla Karpova, Marina A. Gritsenko, Jennifer E. Kyle, Song Cao, Yize Li, Dmitry Rykunov, Antonio Colaprico, Joseph H. Rothstein, Runyu Hong, Vasileios Stathias, MacIntosh Cornwell, Francesca Petralia, Yige Wu, Boris Reva, Karsten Krug, Pietro Pugliese, Emily Kawaler, Lindsey K. Olsen, Wen-Wei Liang, Xiaoyu Song, Yongchao Dou, Michael C. Wendl, Wagma Caravan, Wenke Liu, Daniel Cui Zhou, Jiayi Ji, Chia-Feng Tsai, Vladislav A. Petyuk, Jamie Moon, Weiping Ma, Rosalie K. Chu, Karl K. Weitz, Ronald J. Moore, Matthew E. Monroe, Rui Zhao, Xiaolu Yang, Seungyeul Yoo, Azra Krek, Alexis Demopoulos, Houxiang Zhu, Matthew A. Wyczalkowski, Joshua F. McMichael, Brittany L. Henderson, Caleb M. Lindgren, Hannah Boekweg, Shuangjia Lu, Jessika Baral, Lijun Yao, Kelly G. Stratton, Lisa M. Bramer, Erika Zink, Sneha P. Couvillion, Kent J. Bloodsworth, Shankha Satpathy, Weiva Sieh, Simina M. Boca, Stephan Schurer, Feng Chen, Maciej Wiznerowicz, Karen A. Ketchum, Emily S. Boja, Christopher R. Kinsinger, Ana Robles, Tara Hiltke, Mathangi Thiagarajan, Alexey Nesvizhskii, Bing Zhang, D. R. Mani, Michele Ceccarelli, Xi S. Chen, Sandra L. Cottingham, Qing Kay Li, Albert H. Kim, David Fenyo, Kelly Ruggles, Henry Rodriguez, Mehdi Mesri, Samuel H. Payne, Adam C. Resnick, Pei Wang, Richard D. Smith, Antonio Iavarone, Milan G. Chheda, Jill S. Barnholtz-Sloan, Karin D. Rodland, Tao Liu, Li Ding

Summary: Understanding the molecular pathogenesis of glioblastoma is crucial for improving diagnosis and treatment. Integrated analysis of genomic, proteomic, and metabolomic data on treatment-naive glioblastomas has identified key phosphorylation events and potential targets for specific tumor alterations. Immune subtypes with distinct immune cell types were discovered, and specific histone acetylation patterns were correlated with these subtypes, providing insights for stratification of patients for more effective treatment.

CANCER CELL (2021)

Article Oncology

The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients

Mei Jiang, Aline F. Fares, Daniel Shepshelovich, Ping Yang, David Christiani, Jie Zhang, Kouya Shiraishi, Brid M. Ryan, Chu Chen, Ann G. Schwartz, Adonina Tardon, Sanjay Shete, Matthew B. Schabath, M. Dawn Teare, Loic Le Marchand, Zuo-Feng Zhang, John K. Field, Hermann Brenner, Nancy Diao, Juntao Xie, Takashi Kohno, Curtis C. Harris, Angela S. Wenzlaff, Guillermo Fernandez-Tardon, Yuanqing Ye, Fiona Taylor, Lynne R. Wilkens, Michael Davies, Yi Liu, Matt J. Barnett, Gary E. Goodman, Hal Morgenstern, Bernd Holleczek, Sera Thomas, M. Catherine Brown, Rayjean J. Hung, Wei Xu, Geoffrey Liu

Summary: The relationship between BMI and overall survival in non small-cell-lung-cancer patients is affected by factors such as race, sex, and smoking status. Underweight and obese female ever-smokers had worse outcomes in White patients, while Black patients showed more favorable outcomes in extremes of BMI. BMI was least associated with survival in Asian patients and never-smokers.

LUNG CANCER (2021)

Article Oncology

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells

Akihiko Miyanaga, Masaru Matsumoto, Jessica A. Beck, Izumi Horikawa, Takahiro Oike, Hirokazu Okayama, Hiromi Tanaka, Sandra S. Burkett, Ana I. Robles, Mohammed Khan, Delphine Lissa, Masahiro Seike, Akihiko Gemma, Hiroyuki Mano, Curtis C. Harris

Summary: Chromosomal inversions involving ALK and EML4 generate fusion protein EML4-ALK in NSCLC. Functional study on normal human cells revealed that EML4-ALK induces cellular senescence and accelerated proliferation, with different signaling pathways contributing to the phenotypic outcomes. The expression of hTERT is critical for EML4-ALK to manifest its in vitro transforming activity in human cells.

BMC CANCER (2021)

Review Oncology

JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance

Hatem E. Sabaawy, Brid M. Ryan, Hossein Khiabanian, Sharon R. Pine

Summary: Inflammation plays a crucial role in carcinogenesis, tumor progression, and treatment resistance. The JAK/STAT signaling pathway is central to mediating cellular response to inflammation and contributes to cancer development by regulating cell proliferation, survival, and interaction with the immune microenvironment. Additionally, JAK/STAT activation modulates tumor cell responses to therapy, highlighting its significance in cancer progression and treatment.

CARCINOGENESIS (2021)

Article Biochemistry & Molecular Biology

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Liwei Cao, Chen Huang, Daniel Cui Zhou, Yingwei Hu, T. Mamie Lih, Sara R. Savage, Karsten Krug, David J. Clark, Michael Schnaubelt, Lijun Chen, Felipe da Veiga Leprevost, Rodrigo Vargas Eguez, Weiming Yang, Jianbo Pan, Bo Wen, Yongchao Dou, Wen Jiang, Yuxing Liao, Zhiao Shi, Nadezhda Terekhanova, Song Cao, Rita Jui-Hsien Lu, Yize Li, Ruiyang Liu, Houxiang Zhu, Peter Ronning, Yige Wu, Matthew A. Wyczalkowski, Hariharan Easwaran, Ludmila Danilova, Arvind Singh Mer, Seungyeul Yoo, Joshua M. Wang, Wenke Liu, Benjamin Haibe-Kains, Mathangi Thiagarajan, Scott D. Jewell, Galen Hostetter, Chelsea J. Newton, Qing Kay Li, Michael H. Roehr, David Fenyo, Pei Wang, Alexey Nesvizhskii, D. R. Mani, Gilbert S. Omenn, Emily S. Boja, Mehdi Mesri, Ana Robles, Henry Rodriguez, Oliver F. Bathe, Daniel W. Chan, Ralph H. Hruban, Li Ding, Bing Zhang, Hui Zhang

Summary: This study conducted comprehensive proteogenomic analysis of PDAC to understand the molecular alterations that drive oncogenesis. Multiple analyses were performed on tissues from patients, providing valuable resources for early detection and identification of therapeutic targets.
Article Biochemistry & Molecular Biology

A proteogenomic portrait of lung squamous cell carcinoma

Shankha Satpathy, Karsten Krug, Pierre M. Jean Beltran, Sara R. Savage, Francesca Petralia, Chandan Kumar-Sinha, Yongchao Dou, Boris Reva, M. Harry Kane, Shayan C. Avanessian, Suhas V. Vasaikar, Azra Krek, Jonathan T. Lei, Eric J. Jaehnig, Tatiana Omelchenko, Yifat Geffen, Erik J. Bergstrom, Vasileios Stathias, Karen E. Christianson, David Heiman, Marcin P. Cieslik, Song Cao, Xiaoyu Song, Jiayi Ji, Wenke Liu, Kai Li, Bo Wen, Yize Li, Zeynep H. Gumus, Myvizhi Esai Selvan, Rama Soundararajan, Tanvi H. Visal, Maria G. Raso, Edwin Roger Parra, Ozgun Babur, Pankaj Vats, Shankara Anand, Tobias Schraink, MacIntosh Cornwell, Fernanda Martins Rodrigues, Houxiang Zhu, Chia-Kuei Mo, Yuping Zhang, Felipe da Veiga Leprevost, Chen Huang, Arul M. Chinnaiyan, Matthew A. Wyczalkowski, Gilbert S. Omenn, Chelsea J. Newton, Stephan Schurer, Kelly Ruggles, David Fenyo, Scott D. Jewell, Mathangi Thiagarajan, Mehdi Mesri, Henry Rodriguez, Sendurai A. Mani, Namrata D. Udeshi, Gad Getz, James Suh, Qing Kay Li, Galen Hostetter, Paul K. Paik, Saravana M. Dhanasekaran, Ramaswamy Govindan, Li Ding, Ana Robles, Karl R. Clauser, Alexey Nesvizhskii, Pei Wang, Steven A. Carr, Bing Zhang, D. R. Mani, Michael A. Gillette

Summary: The proteogenomic analysis of LSCC reveals a deeper understanding of its biology and potential therapeutic directions. New therapeutic targets and rationale for further exploration have been identified, along with support for complex regulation of metabolic pathways and immune-related research directions. Furthermore, insights from triangulation with other cancers highlight unique and shared vulnerabilities, guiding future research into LSCC biology and treatment.
Article Multidisciplinary Sciences

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing

Sanju Sinha, Karina Barbosa, Kuoyuan Cheng, Mark D. M. Leiserson, Prashant Jain, Anagha Deshpande, David M. Wilson, Brid M. Ryan, Ji Luo, Ze'ev A. Ronai, Joo Sang Lee, Aniruddha J. Deshpande, Eytan Ruppin

Summary: Recent studies have shown that CRISPR-Cas9 gene editing induces DNA damage response mediated by p53, potentially leading to the selection of cells with pre-existing p53 or KRAS mutations, which may confer a selective advantage. This selection effect extends across cell types and methods of CRISPR-Cas9 delivery, highlighting the need to monitor patients with pre-existing p53 and KRAS mutations undergoing CRISPR-Cas9-based editing for clinical therapeutics.

NATURE COMMUNICATIONS (2021)

Review Oncology

Understanding the role of dopamine in cancer: past, present and future

Christopher E. Grant, Amy L. Flis, Brid M. Ryan

Summary: Dopamine, a neurotransmitter in the central nervous system, has recently emerged as a potential target in cancer treatment. However, the lack of mechanistic data supporting its direct involvement in cancer has limited its translation to the clinic. Nonetheless, the association between dopamine and cells in the tumor microenvironment justifies further investigation.

CARCINOGENESIS (2022)

Correction Multidisciplinary Sciences

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing (vol 12, 6512, 2021)

Sanju Sinha, Karina Barbosa, Kuoyuan Cheng, Mark D. M. Leiserson, Prashant Jain, Anagha Deshpande, David M. Wilson, Brid M. Ryan, Ji Luo, Ze'ev A. Ronai, Joo Sang Lee, Aniruddha J. Deshpande, Eytan Ruppin

NATURE COMMUNICATIONS (2022)

Meeting Abstract Oncology

Proteogenomic and metabolomic characterization of human glioblastoma.

Liang-Bo Wang, Alla Karpova, Marina A. Gritsenko, Jennifer E. Kyle, Song Cao, Yize Li, Dmitry Rykunov, Antonio Colaprico, Joseph Rothstein, Runyu Hong, Vasileios Stathias, MacIntosh Cornwell, Francesca Petralia, Richard D. Smith, Antonio Iavarone, Milan G. Chheda, Jill S. Barnholtz-Sloan, Karin D. Rodland, Tao Liu, Li Ding

CANCER RESEARCH (2021)

No Data Available